Title

Speakers

 

Andrew Adams MD/PhD is Professor of Surgery and Chief of the Division of Transplantation at the University of Minnesota where he holds the John S Najarian Chair in Clinical Transplantation. He is also the Executive Medical Director of the Solid Organ Transplant Service Line at M Health Fairview.

He received a combined MD/PhD with an emphasis in Transplantation Immunology from Emory and subsequently completed his General Surgery Residency at Massachusetts General Hospital, Harvard Medical School. He returned to Emory and completed a fellowship in Transplant Surgery where he remained as a faculty member until joining the University of Minnesota in September of 2020.

His research efforts are concentrated on the development of novel strategies and therapeutics to promote transplantation tolerance.  He has made important contributions to our understanding concerning the interplay between viral infection, immune memory and the allo-immune response. He is also an internationally recognized expert in large animal models of xenotransplantation (pig-to-non-human primate organ transplant).

His clinical practice is focused on abdominal organ transplantation with a focus on liver & kidney transplantation in both adult and pediatric patients. One of his primary clinical research interests is resource utilization following kidney transplantation including defining the factors that drive increased burden of hospitalization and inferior outcomes. He has mentored numerous pre-doctoral students, post-doctoral fellows and PhD and MD-PhD candidates. He and his trainees have received numerous awards from professional societies.

 

Deb Adey

Dr. Adey is a Transplant Nephrologist and Medical Director for Kidney Transplantation at the University of California, San Francisco (UCSF). After her Nephrology Fellowships at the University of Vermont and Mayo Clinic, Rochester, she joined UCSF as a post-doctoral fellow doing research in the field of recurrent Focal Segmental Glomerulosclerosis with Drs. David Lovett and Flavio Vincenti. The research resulted in her receiving a Young Investigator award in 1997 from the American Society of Transplant Physicians.  She remained at UCSF from 1996-2009 as faculty, until taking a position at the University of Vermont as the Medical Director for their transplant program in 2009.  She returned to California in 2012, joining the University of California, Davis transplant program where she was the Medical Director of the Living Donor Program and the lead physician for the Pediatric to Adult transition program.  She returned to UCSF in 2015 where she is currently the Medical Director of the UCSF Kidney Transplant Program.  Her research interests have been predominantly clinical research in the area of desensitization and antibody mediated rejection as well as BK viral infections post-transplantation. Her academic focus has been in Transplant Nephrology training and education. Currently she is working with Dr. Elaine Ku to institute a clinical research outcomes data base, called MATCH, Multidisciplinary Advancement of Transplant Centered Health. She was the Transplant Nephrology Fellowship Program Director at UCSF from 2002-2009.   

She has been actively involved in the American Society of Transplantation (AST) throughout her career, having served on the Education Committee, the Membership committee (served as chair), the Accreditation committee (served as chair), as well as several communities of practice (COP). She was chair of the Womens Health community of Practice, and a member of the living donor COP, the pediatric COP and involved in pediatric to adult transition, the Infectious Disease COP, as well as the Kidney Pancreas COP. Currently she is a member of the AST Conflict of Interest Committee and the AST OPTN/UNOS committee. She served on the Board of Directors as a councilor at large from 2017-2020. She also had the opportunity to serve on the UNOS Ethics committee for three years 2009-2012.  

 

 

 

 

 

 

 

 

 

 

 

 

 

Maria-Luisa Alegre, MD, PhD

The Alegre laboratory is interested in T cell responses in settings of transplantation, autoimmunity and cancer, with an emphasis on mouse models and emerging extensions onto clinical translation. A main focus of the laboratory is on T cell tolerance in transplantation and how infections and inflammatory events can affect induction or maintenance of tolerance. The Alegre lab in collaboration with the Chong lab have found that transplantation tolerance can exist at different levels of robustness based on the number of mechanisms of T cell tolerance that are engaged, and that infections or inflammation can erode such tolerance. The impact of bacterial infections on transplant outcomes has led the Alegre lab to discover that the microbiota also influences immune responses to transplanted organs and can be manipulated to prolong graft survival. Similarly, the Alegre lab has shown that environmental factors that influence the microbiota composition, such as obesity and exercise, also affect the immune responses against transplanted organs and the kinetics of transplant rejection. Clinical studies have focused on the immunology of transplant recipients and of patients infected with the bacteria that influence transplant outcomes and, collaboratively, on the involvement of the microbiota in the responsiveness of melanoma patients to immunotherapy.  

 

 

 

 

 

 

Dr. Judith Anesi is an Assistant Professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Anesi is board certified in Internal Medicine and Infectious Diseases, and is an Attending Physician in Transplant Infectious Diseases at the Hospital of the University of Pennsylvania. Dr. Anesi is the recipient of federal grants from the NIH, CDC, and the Antibacterial Resistance Leadership Group for her research on the clinical and molecular epidemiology of bacterial infections among solid organ transplant recipients, with a particular expertise in donor-derived bacterial infections and multidrug-resistant organisms.

Dr. Anesi received her undergraduate degree in Biological Sciences from the University of Chicago. She received her Medical Degree from Weill Cornell Medical School of Cornell University and performed her internship and residency training in Internal Medicine at Massachusetts General Hospital. She completed her fellowship in Infectious Diseases and a Master of Science in Clinical Epidemiology (MSCE) degree at the University of Pennsylvania.

 

Jamil Azzi is an Associate Professor of Medicine at Harvard Medical School.  He is the medical director of the vascularized composite allo-transplantation (VCA) and the associate director of the kidney and pancreas transplant at Brigham and Women’s Hospital. Dr. Azzi is a physician scientist who is leading a NIH funded laboratory that focuses on understanding the immune-regulatory arm of the immune system in transplantation, autoimmunity and cancer with the goal of developing more targeted and safer therapeutic strategies. Currently, a major focus of his research is CD4 and CD8 regulatory T cells and their activation induced cell death in addition to engineering cell therapies. Dr. Azzi’s laboratory is also exploring multiple genomics and proteomics approaches to develop biomarkers that noninvasively detect rejection in kidney transplant recipients and measure the immune function of immunosuppressed patients.

 

Dr. Lyndsey Bowman is an abdominal organ transplant pharmacotherapy specialist, Co-Residency Program Director of the PGY2 Solid Organ Transplant (SOT) Residency Program, and clinical coordinator for the transplant pharmacists at Tampa General Hospital (TGH). Dr. Bowman has been practicing in the field of SOT for 14 years following pharmacy school at St. Louis College of Pharmacy and two years of residency training at the Medical University of South Carolina. She joined the transplant team at TGH in 2015 after practicing at Barnes-Jewish Hospital/Washington University School of Medicine in St. Louis for the 8 years prior. 

Lyndsey has been actively involved within the American Society of Transplantation (AST) since 2007 and currently chairs AST’s Community Education Committee. As a former Member-at-Large on the AST Transplant Pharmacy Community of Practice (TxPharm COP) Executive Committee, Lyndsey led the further development of the online community HUB and online programming for the TxPharm COP. On the Education Subcommittee of the TxPharm COP for 4 consecutive years, she helped to develop numerous programs for the American Transplant Congress. Lyndsey currently serves on the Public Policy Workgroup for the AST TxPharm COP and provides service to other professional organizations as the immediate past chair of the Immunology and Transplantation Practice and Research Network (IMTR PRN) for the American College of Clinical Pharmacy.

 

Anita Chong received her PhD in cell biology from the Australian National University, and is currently a Professor in the Section of Transplant at The University of Chicago, USA. She has a long-standing interest in transplantation immunology, and research efforts in her laboratory focusses on immunological tolerance following allogeneic transplantation and the impact of sensitization, as well as on the control of humoral immunity.  Her findings have led to pilot clinical trials for the treatment of antibody-mediated rejection and desensitizing patients for transplantation. 

Anita has won numerous awards for her research including the 2015 Basic Science Established Investigator Award from The American Society of Transplantation, 2020 Women Leader in Transplantation Award and the 2020 Distinguished Fellow of the American Association for the Advancement of Science.  She has published 200 research articles, book chapters and reviews, and has received over 50 research awards from the National Institutes of Health, research foundations and industry.  Anita has served on grant review panels and the Advisory Council of the National Institute of Allergy, Immunology and Infectious Diseases at the National Institutes of Health, and on the Advisory Board of Immune Tolerance Network.  She was the Chair of the Basic Science Committee of the Transplantation Society (2010-2016) and is currently the Co-chair of the Community of Transplantation Scientists, American Society of Transplantation, and Pillar 1 Chair of the Women in Transplantation (WIT) Initiative.

 

Matthew Cooper is a Professor of Surgery at Georgetown School of Medicine and the Director of Kidney and Pancreas Transplantation at the Medstar Georgetown Transplant Institute (MGTI).

After receiving his medical degree from the Georgetown University School of Medicine in 1994, Dr Cooper completed his general surgery training at the Medical College of Wisconsin followed by a fellowship in multi-organ abdominal transplantation in 2002 at the Johns Hopkins Hospital in Baltimore, MD. He joined the transplant faculty at the Johns Hopkins Hospital upon completion of his training and was appointed Surgical Director of Kidney Transplantation and Clinical Research in 2003.  Dr. Cooper joined the University of Maryland in 2005 directing the kidney transplant and clinical research program until 2012 following which he assumed his current role in Washington, DC.

Dr. Cooper trained with the pioneers of the laparoscopic donor nephrectomy procedure and seeks new opportunities for living donation through innovation and by removing the disincentives for those considering donation while promoting the safety and long-term care of live organ donors.  His clinical interests included kidney and pancreas transplantation; particularly the use of marginal organs and has recently chaired both an NKF sponsored Task Force to decrease kidney allograft discards and a UNOS-sponsored System Performance Improvement Committee which have led to several exciting projects to potentially bring more patients an opportunity for transplantation.  Dr. Cooper is involved in several ongoing clinical research projects primarily with an interest in immunosuppression minimization and amelioration of delayed graft function in kidney allografts following ischemic reperfusion injury. He has authored over 200 peer-reviewed manuscripts, 300 abstracts and 12 book chapters. He is regularly invited to speak on a variety of transplant-related topics both nationally and internationally.

Dr. Cooper is involved in transplantation activities both locally in the District and on a national basis.  He is the current UNOS/OPTN President.  He is a member of the National and DC Board of Directors for the NKF and a member of the NKF’s National Transplant Task Force and Public Policy Committee.  He has served as the chairman of the United Network of Organ Sharing (UNOS) Living Donor Committee and recently acted as the Councillor for UNOS’ Region 2.  He is a current councillor for the American Society of Transplant Surgeons.  He is a current board member for the National Kidney Registry, the American Foundation for Donation and Transplantation, the International Pancreas and Islet Cell Transplant Association, Donate Life America and the local OPO – Washington Regional Transplant Community.  Dr. Cooper has served as Chair of the American Transplant Congress.

 

 

 

 

 

 

 

 

 

Paolo Cravedi, MD, PhD, is an Associate Professor in the Division of Nephrology in the Department of Medicine. Dr. Paolo Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. During his clinical training as nephrologist in Italy, he designed clinical research studies in kidney transplant recipients and in individuals with renal diseases aimed at prolonging survival of the graft or the native kidneys, respectively. His studies have contributed to defining the organ allocation system currently used in many countries around the world. 
He subsequently completed his postdoctoral training at the Icahn School of Medicine at Mount Sinai, where he identified unanticipated immune effects of erythropoietin. While Dr. Cravedi’s lab is still interested in understanding the mechanisms of alloreactive immune responses, it has more recently expanded its focus to study the pathogenesis of autoimmune glomerular disease.

 

Christina Doligalski, PharmD, BCPS, CPP, FAST, FCCP

Dr. Doligalski is the Cardiothoracic Transplant Clinical Pharmacist Practitioner at the University of North Carolina at Chapel Hill Healthcare and Assistant Professor of Clinical Education, UNC Eshelman School of Pharmacy. Additionally, she serves as the Program Director for the PGY2 Solid Organ Transplant Pharmacy Residency Program. Prior to her current position, Dr. Doligalski completed her PGY1 and PGY2 Solid Organ Transplant residencies at Duke University Hospital and served as the Cardiac Transplant Pharmacotherapy Specialist at Tampa General Hospital.

 

 

 

          

Robert L. Fairchild received a doctorate in immunology at the University of Missouri-Columbia and completed a postdoctoral fellowship in the Division of Clinical Immunology at the University of Colorado and the National Jewish Center for Allergy and Respiratory Medicine in Denver. He is a Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine and a Professor in the Department of Pathology at Case Western Reserve University School of Medicine in Cleveland, Ohio.

Dr. Fairchild has served on many NIH study sections and is former Chair of the Tumors, Transplantation, and Tolerance (TTT) study section.  He has served as Co-Chair of the American Transplant Congress and the American Society of Transplantation Fellows Symposium.  He has served as Deputy Editor for the Journal of Immunology and for the American Journal of Transplantation and is currently on the editorial boards for the American Journal of Transplantation, Current Transplant Reports, and Kidney International.

Dr. Fairchild’s research program focuses on mechanisms of endogenous CD8 memory T cell activity on allograft outcome and on mechanisms underlying antibody mediated rejection of kidney allografts using both mouse models and samples from transplant patients.

 

Samira Farouk MD, MSCR, FASN, is a transplant nephrologist at the Icahn School of Medicine at Mount Sinai (ISMMS). She is an Assistant Professor of Medicine and Medical Education, Associate Program Director of the Nephrology Fellowship Program, and Social Media Director of the Division of Nephrology. Dr. Farouk is a graduate of Princeton University where she received her B.S.E in Chemical Engineering with a certificate in Spanish and Portuguese Language and Culture. She received her MD from Rutgers University – Robert Wood Johnson Medical School where she graduated with a Distinction in Research. She completed her internship, residency, and nephrology and transplant fellowship at the Icahn School of Medicine at Mount Sinai and also served as chief fellow. 

Dr. Farouk is involved in all levels of medical education and teaches medical students, residents, and fellows and has been the recipient of multiple teaching awards. She is interested in the development and study of innovative medical education tools and technologies, including free open access medical education (FOAMed) and social media. She is the co-founder of NephSIM winner of the 2018 American Society of Nephrology Innovations in Kidney Education contest, co-faulty lead of Renal Fellow Network, and Executive Committee member of NephMadness and the Nephrology Social Media Collective. Dr. Farouk serves on the Editorial Board of journals including the American Journal of Kidney Diseases, Kidney News, Clinical Transplantation, and the Journal of Nephrology and is a member of committees of the ASN and American Society of Transplantation.